Craig C. Carson

发表

Genome-wide regulatory analysis using en masse nuclear run-ons emRUNs and ribonomic profiling with autoimmune sera

Ulus Atasoy, Jack D. Keene, S. Tenenbaum, 2003 .

Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays.

S. Tenenbaum, J. Keene, P. Lager, 2002, Methods.

Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays.

S. Tenenbaum, J. Keene, P. Lager, 2000, Proceedings of the National Academy of Sciences of the United States of America.

DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features

K. Conway, S. Edmiston, M. Berwick, 2014, Pigment cell & melanoma research.

Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees.

M. Petri, G. Koelsch, S. Henshall, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.

M. Wilkerson, J. Parker, K. Conway, 2019, The Journal of investigative dermatology.

Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma

Derek Y. Chiang, J. Parker, N. Sharpless, 2014, Pigment cell & melanoma research.

Mechanisms of chromosomal instability in melanoma

B. Omolo, J. M. Shields, W. Kaufmann, 2014, Environmental and molecular mutagenesis.

MERTK receptor tyrosine kinase is a therapeutic target in melanoma.

C. Miller, S. Frye, J. M. Shields, 2013, The Journal of clinical investigation.

A prognostic signature of defective p53‐dependent G1 checkpoint function in melanoma cell lines

H. Chu, C. Fan, J. Ibrahim, 2012, Pigment cell & melanoma research.

Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922)

J. Serody, A. Ivanova, E. Dees, 2021, Melanoma research.

DNA-methylation profiling distinguishes malignant melanomas from benign nevi

H. Chu, K. Conway, S. Edmiston, 2011, Pigment cell & melanoma research.

Selection of a subset of mRNAs from combinatorial 3' untranslated region libraries using neuronal RNA-binding protein Hel-N1.

J. Keene, C. Carson, F. Gao, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Effective intra‐S checkpoint responses to UVC in primary human melanocytes and melanoma cell lines

J. Ibrahim, W. Kaufmann, D. Simpson, 2016, Pigment cell & melanoma research.

P-Rex1 is required for efficient melanoblast migration and melanoma metastasis.

I. Jackson, J. Norman, C. Der, 2011, Nature communications.

A prognostic signature of G₂ checkpoint function in melanoma cell lines

H. Chu, J. Ibrahim, R. Paules, 2013, Cell cycle.

IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma

C. Miller, David B. Darr, N. Sharpless, 2015, Clinical Cancer Research.